Clinical Trial Update: Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase [Phase 3]

View source ↗

Summary

The ASPIRING trial (pilot Phase 3) evaluating antiplatelet secondary prevention after intracerebral hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Snippet

Sponsor: The George Institute for Global Health, China | Conditions: Intracerebral Hemorrhage | Phase 3 | Status: COMPLETED